The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

New research comparing different approaches to dementia care for people with Alzheimer's disease and other dementias found no ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

The widely used PDF format supports data-saving encryption, allowing you to protect sensitive documents so that only those with the correct password can access them. In the old days, you’d need a ...

In addition to the most cutting-edge and expert-backed smarter living advice in the categories of wellness, health, ...

Background: There is a gap between the principles of person-centred dementia care and their actual implementation. However, scoping reviews of the barriers and facilitators to implementing ...

In this video interview, Kimberly Tableman, founder & CEO, ESPERO, discusses historical challenges with long protocol development timelines and how they can be addressed. In a recent video interview ...

Creating two distinct classifications of “clinical obesity” and “pre-clinical obesity” would provide more accurate diagnosis and more personalised treatment, it argued.

People with Alzheimer’s and other types of dementia tend to be at a high risk of falling. They are more than three times more likely to fracture their hip when they fall, which leads to surgery and ...

Progress in dementia research and clinical care has continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild ...